Diseases /
T-Cell Large Granular Lymphocyte Leukemia
Back to Diseases List
Associated Genetic Biomarkers
Overview
NCI Definition: A T-cell peripheral neoplasm characterized by a persistent (>6 months) increase in the number of peripheral blood large granular lymphocytes, without a clearly identified cause. (WHO, 2001) [1]
T-cell large granular lymphocyte leukemias most frequently harbor alterations in STAT3, TET2, KMT2A, WT1, and TNFAIP3 [2].
STAT3 Mutation, STAT3 Exon 21 Mutation, TET2 Mutation, STAT3 Y640F, and TET2 Nonsense are the most common alterations in T-cell large granular lymphocyte leukemia [2].
Disease Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.